REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Hsu, Diane
Lee, Justin
Kotzen, Alison
Bensen, Rachel
Goyal, Alka
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2024年 / 30卷
关键词：
D O I：
10.1093/ibd/izae020.159
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
izae020.15
引用
收藏
页码：S73 / S74
页数：2
相关论文
共 50 条
  • [11] Real-world effectiveness and safety of ustekinumab and vedolizumab in elderly patients with Crohn's disease
    Garg, Rajat
    Aggarwal, Manik
    Mohammed, Abdul
    Achkar, Jean Paul
    Lashner, Bret
    Philpott, Jessica
    Cohen, Benjamin
    Qazi, Taha
    Rieder, Florian
    Regueiro, Miguel
    Click, Benjamin
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2023, 42 (05) : 718 - 723
  • [12] REAL-WORLD EFFECTIVENESS AND SAFETY OF USTEKINUMAB AND VEDOLIZUMAB IN ELDERLY PATIENTS WITH CROHN'S DISEASE
    Garg, Rajat
    Aggarwal, Manik
    Mohammed, Abdul
    Achkar, Jean-Paul
    Lashner, Bret
    Philpott, Jessica
    Cohen, Benjamin L.
    Rieder, Florian
    Qazi, Taha
    Regueiro, Miguel D.
    Click, Benjamin H.
    GASTROENTEROLOGY, 2021, 160 (06) : S560 - S560
  • [13] Safety and Efficacy of Ustekinumab and Vedolizumab Among Older Adults With Inflammatory Bowel Disease
    Sachar, Moniyka
    Fernandez, Cristina
    Beaty, William
    Rojanasopondist, Pakdee
    Delau, Olivia
    Li, Alice
    Murphy, Megan
    Axelrad, Jordan
    Hong, Simon J.
    Holmer, Ariela
    Chang, Shannon
    Hudesman, David
    Katz, Seymour
    Malter, Lisa
    Faye, Adam S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S866 - S867
  • [14] Real World Experience of Vedolizumab in Pediatric Inflammatory Bowel Disease
    Whitney, Annette
    Sarles, Harry E., Jr.
    Claudia, Schroeder P.
    Okoro, Tracy C.
    Van Anglen, Lucinda J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S396 - S396
  • [15] Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease
    Kotze, Paulo G.
    Ma, Christopher
    Almutairdi, Abdulelah
    Al-Darmaki, Ahmed
    Devlin, Shane M.
    Kaplan, GilaadG.
    Seow, Cynthia H.
    Novak, Kerri L.
    Lu, Cathy
    Ferraz, Jose G. P.
    Stewart, Michael J.
    Buresi, Michelle
    Jijon, Humberto
    Mathivanan, Meena
    Heatherington, Joan
    Martin, Marie-Louise
    Panaccione, Remo
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (06) : 626 - 637
  • [16] Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease
    Brian Bressler
    Jennifer Jones
    Tracy S. H. In
    Tommy Lan
    Cristian Iconaru
    John K. Marshall
    Advances in Therapy, 2023, 40 : 4421 - 4439
  • [17] Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease
    Bressler, Brian
    Jones, Jennifer
    In, Tracy S. H.
    Lan, Tommy
    Iconaru, Cristian
    Marshall, John K.
    ADVANCES IN THERAPY, 2023, 40 (10) : 4421 - 4439
  • [18] Real-world efficacy and safety of vedolizumab among patients with inflammatory bowel disease: A single tertiary medical center experience in Central Taiwan
    Chiu, Yu-Chiao
    Chen, Chia-Chang
    Ko, Chung-Wang
    Liao, Szu-Chia
    Yeh, Hong-Zen
    Chang, Chung-Hsin
    ADVANCES IN DIGESTIVE MEDICINE, 2021, 8 (01) : 40 - 46
  • [19] Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Hather, Greg
    Demuth, Dirk
    Mosli, Mahmoud
    Curtis, Rebecca
    Khalid, Javaria Mona
    Loftus, Edward Vincent, Jr.
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (09) : 1048 - 1064
  • [20] Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
    Stefan Schreiber
    Axel Dignass
    Laurent Peyrin-Biroulet
    Greg Hather
    Dirk Demuth
    Mahmoud Mosli
    Rebecca Curtis
    Javaria Mona Khalid
    Edward Vincent Loftus
    Journal of Gastroenterology, 2018, 53 : 1048 - 1064
12345